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Abstract
Terminal erythroid differentiation in mammals is the process whereby nucleated precursor cells accumulate erythroid-specific proteins such as
hemoglobin, undergo extensive cellular and nuclear remodeling, and ultimately shed their nuclei to form reticulocytes, which then become mature
erythrocytes in the circulation. Little is known about the mechanisms that enable erythroblasts to undergo such a transformation. We hypothesized
that genes involved in these mechanisms were likely expressed at restricted times during the differentiation process and used differential display
reverse transcriptase polymerase chain reaction as a first step in identifying such genes. We identified three differentially expressed cDNAs that we
termed late erythroblast (LEB) 1–3. None of these cDNAs were previously identified as being expressed in erythroblasts and their patterns of
expression indicated they are likely to be involved in the differentiation process. LEB-1 cDNA was derived from the gene A330102K04Rik
(approved gene symbol Apoll1), and shares homology with members of the apolipoprotein L family in humans. LEB-3 cDNAwas derived from
the novel gene D930015E06Rik, that has no known function. LEB-2 cDNAwas derived from the gene ranBP16 (approved gene symbol Xpo7), a
nuclear exportin. D930015E06Rik mRNA is also strongly expressed in the testis and was localized to a region of the seminiferous tubule where
secondary spermatocytes and early spermatids are found, suggesting a role for D930015E06Rik in spermatogenesis as well as terminal erythroid
differentiation. We have thus identified three genes not previously described as being expressed in erythroblasts that could be relevant in
elucidating mechanisms involved in terminal erythroid differentiation.
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erythrocytes in mammals is known as terminal erythroid
differentiation. Mammalian erythrocytes are unique among
vertebrates in that they typically shed their nuclei and undergo a
dramatic shape change to become fully functional erythrocytes.
Early studies in the field largely involved descriptions of the
differentiation process at the light and electron microscopic
levels [reviewed in 1], whereas later studies included biochem-
ical analyses of the structure of the erythrocyte membrane and
membrane cytoskeleton [2–9]. The growth factors involved in
regulation of the process, such as erythropoietin (EPO), have☆ Sequence data from this article have been deposited with the GenBank Data
Library under Accession Nos. AY662646, AY550930, and AY662647.
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doi:10.1016/j.ygeno.2007.06.010been studied in great detail [reviewed in [10]. Studies of
transcription factors, such as GATA-1, have yielded many
insights into the global control of erythroid-specific genes and
the regulation of erythroid terminal differentiation [reviewed in
[11]. Such studies have resulted in a better understanding of the
functions of the components of the mature erythrocyte, the
mechanisms of action of the growth factors, and a number
human diseases involving abnormalities of one or more of the
components of the mature erythrocyte. Despite the many ad-
vances in understanding the function of the mature erythrocyte
and EPO control of the process of erythropoiesis, little has been
learned about a number of the fundamental processes involved
in terminal erythroid differentiation.
The terminal differentiation of mammalian definitive
erythroblasts is characterized by a number of distinct processes.
These processes include the condensation and transcriptional
inactivation of chromatin, accumulation of erythroid-specific
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of proteins and organelles not found in the mature erythrocyte,
nuclear extrusion, and membrane skeletal remodeling. Little is
known about how many of these processes occur, but a number
of them are likely to involve gene products expressed at
restricted times in the differentiation process. Elucidation of
mechanisms involved in the processes would be greatly
enhanced by the identification of such genes.
The cell model used in this study involves erythroblasts
isolated from the spleens of mice infected by the anemia-
inducing strain of the Friend leukemia virus (FVA cells) [12].
FVA cells can be isolated at a stage of differentiation that
approximates proerythroblasts. The very large majority of FVA
cells mature into reticulocytes within a 48- to 72-hour period
when they are cultured in the presence of physiological
concentrations of the hormone EPO. FVA cells exhibit all of
the in vivo characteristics of maturing erythroblasts and have
been used successfully in many studies of erythroid terminal
differentiation and apoptosis [3,13–26], from which findings in
FVA cells have translated well to uninfected murine and human
erythroblasts. FVA cells have also recently been used to identify
a number of reported cytoplasmic factors, called erythroid
differentiation denucleation factors, that mediate events late in
terminal differentiation [27].
This article describes our initial characterization of three
genes not previously known to be preferentially expressed at the
most terminal stages of erythroid differentiation. Two of the
three represent hypothetical genes identified through sequen-
cing of the mouse genome that have no known function, while
the third encodes a protein (ranBP16 or Xpo7) [28,29] that is
involved in trafficking molecules out of the nucleus.
Results and discussion
Differential display reverse transcriptase polymerase chain
reaction (DDRT-PCR)
Complementary DNA fragments representing mRNAs that
were expressed at higher levels in the late stages of terminal
erythroid differentiation were identified by DDRT-PCR using
an anchor primer with the sequence 5′-dT11CA in combina-
tion with 12 different arbitrary primers (data not shown).
Differentially expressed cDNA fragments were successfully
isolated from 6% acrylamide/urea sequencing gels and ream-
plified with appropriate combinations of anchor and arbitrary
primers. Three of the cDNAs, initially referred to as late
erythroblast (LEB) 1–3, that appeared to be the most highly
induced were cloned and sequenced to determine their identity.
The sizes of the LEB cDNA fragments were as follows: LEB-
1, 160 bp; LEB-2, 225 bp; and LEB-3, 208 bp. Northern blot
analyses using these radiolabeled clones as probes confirmed
that the mRNAs of all three were more highly expressed in
FVA cells at the most terminal stages of their differentiation.
The LEB-1 probe hybridized to an mRNA of approximately
2.3 kb in size, while probes specific for LEB-2 and LEB-3
hybridized to large mRNAs in excess of 4 kb in size
(not shown). Larger clones were then obtained for LEB-1,LEB-2, and LEB-3 using 5′-rapid amplification of cDNA ends
(5′-RACE).
LEB-1
An apparent full-length 2.3-kb LEB-1 cDNA was isolated
by 5′-RACE (GenBank Accession No. AY662646). Initial se-
quence analyses of the LEB-1 clone, prior to the complete
sequencing of the mouse genome, indicated that it was a novel
cDNA. We could not, however, identify a long open reading
frame in the sequence, suggesting it might contain intronic
sequences or that the LEB-1 clone was not a full-length cDNA.
When this clone was labeled and used as a probe on Northern
blots of FVA cells and a variety of other mouse tissues, a
transcript of the same size as that detected with the DDRT-PCR
probe was identified. The transcript was strongly expressed in
FVA cells and also detected in normal mouse spleen after a
prolonged exposure (Fig. 1A). An apparently related transcript
of significantly greater size was found in small and large
intestine (lanes LI and SI in Fig. 1A). A region on mouse
chromosome 15 D3 was found to contain several predicted
genes with significant homology to LEB-1 when the LEB-1
cDNA sequence was subjected to BLAST analysis with the
completed mouse genome database. A 2262-bp region of
the LEB-1 cDNA exhibited greater than 98% homology with
the four exons of a gene predicted in this region known as Apoll1
(GenBank Accession No. A330102K04Rik). Apoll1 shares
similarity with the apolipoprotein L family of proteins [30].
However, bases 517 through 2258 of the LEB-1 cDNA also
exhibited approximately 85% homology with the last exon of
another related gene predicted to exist at this locus (GenBank
Accession No. 9030421J09Rik). In addition, bases 1115–2260
exhibited 74% homology with a fragment of the 3′ untranslated
region of Dppa2 (GenBank Accession No. NM_138815), a
gene found to be associated with pluropotentiality during em-
bryonic development [31].
An independent LEB-1 clone was obtained after RT-PCR
using primers based on the coding sequence of Apoll1. The RT-
PCR product was cloned, sequenced, and used in Northern
analyses. The sequence of the RT-PCR clone matched that of
Apoll1 (data not shown). The clone detected a mRNA on
Northern blots of FVA cells that was of the same size and
expressed in the same way as the one identified with both the
DDRT-PCR- and 5′-RACE-generated LEB-1 clones, demon-
strating that LEB-1 was identical to Apoll1. Fig. 2A illustrates
the results of the Northern analysis using the LEB-1 RT-PCR
clone. There was a 1.9-fold increase in the amount of LEB-1
mRNA during the first 24 h of culture with EPO and a 5.6-fold
increase in LEB-1 mRNA after 48 h of culture in the presence of
EPO compared to the initiation of culture. No hybridization was
detected in either small or large intestine with the RT-PCR clone
(data not shown), suggesting that the RNAs detected in these
tissues with the 5′-RACE clone had homology to sequences
primarily in the 3′ untranslated region of LEB-1 mRNA.
Apoll1 shares homology with the apolipoprotein L family of
proteins in humans, having 36% amino acid homology with
human apolipoprotein L3. The reason for a protein having
Fig. 2. Detection of LEB expression in mouse tissues using RT-PCR-generated
probes. (A) Expression of Apoll1 during the terminal differentiation of FVA
cells. Top, Northern blot probed with the Apoll1 RT-PCR probe. Bottom,
same blot probed with the mouse 18S ribosomal RNA probe. (B) Expression
of Xpo7 during the terminal differentiation of FVA cells. Top, Northern blot
probed with the Xpo7 RT-PCR probe. Bottom, same blot probed with the
mouse 18S ribosomal RNA probe. (C) Expression of D930015E06Rik during
the terminal differentiation of FVA cells. Top, Northern blot probed with the
D930015E06Rik RT-PCR probe. Bottom, same blot probed with the mouse
18S ribosomal RNA probe. Lanes: 2, FVA cells after 2 h of culture with
EPO; 24, FVA cells after 24 h of culture with EPO; 48, FVA cells after 48 h
of culture with EPO; T, testis.
Fig. 1. Detection of LEB expression in mouse tissues using 5′-RACE-
generated probes. (A) Top, Northern blot probed with the LEB-1 5′-RACE
probe. Bottom, RNA samples on blot prior to transfer. U, uterus; SM, skeletal
muscle; Sp, spleen; K, kidney; L, liver; B, cerebrum; LI, large intestine;
T, testis; O, ovary; Lu, lung; H, heart; SI, small intestine; 0, FVA cells at the
initiation of culture; 24, FVA cells after 24 h of culture with EPO; 48, FVA
cells after 48 h of culture with EPO. (B) Top, Northern blot probed with the
LEB-2 5′-RACE probe. Bottom, RNA samples on blot prior to transfer. Labels
for gel lanes are as above. (C) Top, Northern blot probed with the LEB-3
5′-RACE probe. Bottom, RNA samples on blot prior to transfer. Labels for
gel lanes are as above.
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expressed during terminal erythroid differentiation is not
known, but alterations in the lipid composition of erythrocyte
membranes during differentiation have been described. Mature
erythrocytes exhibit asymmetric distribution of lipids between
the inner and the outer leaflets of their plasma membranes [32].
The asymmetry becomes pronounced around the time that
nuclear extrusion and reticulocyte formation take place [33,34].Interestingly, up-regulation of several genes in the apolipopro-
tein L gene locus in humans is associated with the development
of schizophrenia [35] and erythrocytes from schizophrenic
patients have been shown to be deficient in a number of fatty
acids compared to controls [36,37]. We therefore hypothesize
that Apoll1 may play some role in establishing the lipid
composition of erythroid membranes. The subcellular localiza-
tion and possible function of LEB-1/A333102K04 are currently
being investigated.
LEB-2
A 1209-bp clone of LEB-2 (GenBank Accession No.
AY550930) was isolated by 5′-RACE and subjected to a
BLAST search against the mouse genome database. The LEB-2
RACE product exhibited approximately 95% homology with a
gene in the chromosome 14 D1 region known as Ran binding
protein 16 (ranBP16) or Exportin 7 (Xpo7; approved gene
symbol) (GenBank Accession No. NM_015024) [28,29]. The
homology was to portions of three exons and some intronic
sequence of Xpo7. The size of the mRNA encoded by Xpo7 is
4.4 kb, consistent with the size of LEB-2 mRNA detected in
Northern blots containing total RNA isolated from differentiat-
ing FVA cells. The LEB-2 RACE product was used in Northern
analyses and was found to identify the same-sized mRNA as
that identified with the LEB-2 DDRT-PCR product (Fig. 1B).
Xpo7 was strongly expressed during the late differentiation of
FVA cells. No comparable expression was found in other tissues
577S. Koury et al. / Genomics 90 (2007) 574–582on the blot, but under long exposure conditions a weak signal
was detected all lanes (data not shown).
An independent LEB-2 clone was obtained by RT-PCR
using primers based on the sequence of Xpo7. The primers were
picked to be outside of the region contained in the 5′-RACE-
generated clone of LEB-2 to determine if LEB-2 was identical
to Xpo7. The RT-PCR product was cloned, sequenced, and used
in Northern analyses. The sequence of the RT-PCR clone
exactly matched that of Xpo7 (data not shown). The clone
identified an mRNA on Northern blots that was of the same size
and expressed in the same way as the one identified with both
the DDRT-PCR- and 5′-RACE-generated LEB-2 clones,
demonstrating that LEB-2 is identical to Xpo7. Fig. 2B
illustrates the results obtained with the Xpo7 RT-PCR clone.
Xpo7 mRNA was only weakly detected in FVA cells after 2 h
of culture with EPO, but became more prominent over the 48-h
differentiation period, increasing sevenfold. A previous study in
which Northern blots were performed using poly(A) RNA
isolated from mouse tissues, rather than total RNA, as used in
this study, found that Xpo7 was detected in brain, spleen, liver,
kidney, and testes [28]. Interestingly, although no quantitative
analysis of autoradiograms was presented in that study, the level
of Xpo7 expression appeared significantly greater in the spleen
compared to the other tissues when normalized to GAPDH
mRNA levels. Such increased expression is consistent with the
murine spleen being a hematopoietic organ. Our inability to
detect significant Xpo7 gene expression in similar tissues (Fig.
1B) was likely due to the use of total RNA, rather than poly(A)
RNA, in our analyses. Nevertheless, the fact that FVA cells had
easily detectable amounts of Xpo7 mRNA suggests a role for
Xpo7 in terminal differentiation. One reason for high levels of
expression of a nuclear exportin in differentiating FVA cells
could be that the exportin is involved in exporting one or more
molecules from the nucleus otherwise involved in keeping
chromatin transcriptionally active or in the decondensed state.
An alternative explanation is that the retroviral infection of
FVA cells may somehow either increase expression of Xpo7 or
delay shutdown of Xpo7 expression to shuttle viral RNA
sequences out of the nucleus. The latter explanation seems
unlikely in that viral particles can be seen shedding from FVA
cells at the earliest stages of differentiation in vitro by electron
microscopy, but are not observed to be shed at as high a
frequency in more differentiated cells [21]. This time sequence
is exactly the opposite to the pattern of Xpo7 expression
observed during the terminal differentiation of FVA cells.
Nevertheless, distinguishing between the two explanations will
require further study.
LEB-3
A 1100-bp clone of LEB-3 was isolated by 5′-RACE
(GenBank Accession No. AY662647). The LEB-3 5′-RACE
clone had approximately 99% homology with a predicted gene
of unknown function known as D930015E06Rik (GenBank
Accession No. NM_172681) on mouse chromosome 3. The
homology was primarily in exons of the predicted gene.
D930015E06Rik shares approximately 79% nucleotide identityto a related human gene (also of unknown function) (GenBank
Accession No. BC131505), 77% nucleotide identity to a related
gene in the dog (GenBank Accession No. XM_862729), 66%
nucleotide identity to a related gene in the red jungle fowl
(GenBank Accession No. XM_420366), and 47% nucleotide
identity to a related gene in the chimpanzee (GenBank Ac-
cession No. XM_517586). The mRNA for D930015E06Rik is
predicted to be 4794 bases in size, consistent with our size
estimate of LEB-3 mRNA on Northern blots using the LEB-3
DDRT-PCR product as a probe. The LEB-3 5′-RACE clone was
clearly most strongly expressed in differentiating FVA cells
(Fig. 1C), but an mRNA of the same size was also detected in
normal mouse testis (lane T, Fig. 1C).
A new LEB-3 clone was obtained by RT-PCR using primers
based on the sequence of D930015E06Rik. The primers were
picked to be outside of the region contained in the clone of
LEB-3 obtained by 5′-RACE, to determine if LEB-3 was
identical to D930015E06Rik. The RT-PCR product was cloned,
sequenced, and used in Northern analyses. The sequence
of the RT-PCR clone exactly matched that predicted from
D930015E06Rik (data not shown).
Fig. 2C illustrates the results obtained with the
D930015E06Rik RT-PCR clone. The clone identified an
mRNA on Northern blots that was of the same size and was
expressed in the same way as the one identified with both the
DDRT-PCR- and the 5′-RACE-generated LEB-3 clones,
demonstrating that LEB-3 is identical to D930015E06Rik.
D930015E06Rik mRNA was detected throughout the differ-
entiation of FVA cells, but accumulated more dramatically than
either Apoll1 or Xpo7. D930015E06Rik mRNA increased 3-
fold over the first 24 h of culture with EPO and nearly 11-fold
over the 48-h culture period. The D930015E06Rik RT-PCR
clone also recognized an mRNA in testes, just as the LEB-3 5′-
RACE clone did. Expression in the testes was 4-fold higher than
that in FVA cells cultured for 2 h in the presence of EPO when
normalized to 18S ribosomal RNA (Fig. 2C).
Detection of Apoll1 and D930015E06Rik in normal mouse
tissues
End-point RT-PCR was performed using total RNA isolated
from the kidneys and bone marrow from three different female
mice to determine the specificity of expression of Apoll1 and
D930015E06Rik in hematopoietic and a nonhematopoietic
tissue. Xpo7 was not subjected to analysis as it had previously
been identified as being expressed in a number of other
hematopoietic and nonhematopoietic mouse tissues [28]. Total
RNA samples isolated from FVA cells cultured for 48 h in the
presence of EPO and from the testis of a male mouse were
used as positive controls. GAPDHwas used as a positive control
for the RT-PCR. An Apoll1 specific RT-PCR product was
detected in bone marrow samples from all three mice tested
along with the FVA sample (Fig. 3, lanes B1, B2, B3, and FVA).
An Apoll1 product was also detected in two of the three kidney
samples evaluated, but the product was at a significantly lower
intensity than that in the bone marrow samples (Fig. 3, lanes K1
and K2). A D930015E06Rik-specific RT-PCR product was also
Fig. 3. Detection of Apoll1 and D930015E06Rik gene expression in normal
mouse tissues by RT-PCR. Top: cDNA amplified using Apoll1 primers. Middle:
cDNA amplified using D930015E06Rik primers. Bottom: cDNA amplified
using primers specific for GAPDH. K, kidney; B, bone marrow; T, testis; FVA,
FVA cells after 48 h of culture in the presence of EPO. Numbers indicate
whether kidney or bone marrow was from mouse 1, 2, or 3. RT reactions were
prepared as described under Materials and methods and diluted as follows for
the PCR: mouse 1, 1:100; mouse 2, 1:200; mouse 3, 1:100; testis, 1:200; FVA,
1:400.
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as well as in the testis and FVA cell sample (Fig. 3, lanes B1,
B2, B3, T, and FVA). A product was also detected in one
of the kidney samples (Fig. 3, lane K2). A GAPDH-specific
RT-PCR product was detected in all samples tested. No
specific Apoll1 or D930015E06Rik RT-PCR products wereFig. 4. Analysis of D930015E06Rik expression in mouse testis by in situ hybridiza
hybridized with the D930015E06Rik antisense riboprobe. Aggregates of silver grain
magnification photomicrograph of a mouse seminiferous tubule hybridized with the D
no aggregation of silver grains is seen between the basal and the apical regions of the
Silver grains can be seen in greatest density over areas of mouse seminiferous tubu
located. sg, area of tubule where spermatogonia and primary spermatocytes are fou
found; st, area near the lumen of the tubule where late spermatids are found. (D) Hig
seminiferous tubule after hybridization with the sense riboprobe.detected in kidney, bone marrow, testis, or FVA cells when
mock reverse-transcribed total RNA samples (see Materials
and methods) were diluted and subjected to PCR under the
same conditions as the reverse-transcribed total RNA samples
(data not shown). These results confirm expression of Apoll1
and D930015E06Rik in all normal mouse bone marrow
samples tested and suggest less or variable expression in the
kidney as a nonhematopoietic organ.
Localization of D930015E06Rik mRNA in mouse testis
In situ hybridization of testis with a D930015E06Rik 35S-
labeled antisense riboprobe demonstrated specific expression of
D930015E06Rik in restricted areas of the seminiferous tubules
(Figs. 4A and 4C). Hybridization was most intense in the region
in which secondary spermatocytes and early spermatids were
located. Little specific hybridization was observed in the
regions immediately adjacent to the basement membrane
where spermatogonium and primary spermatocytes are located,
nor was there significant hybridization observed over late
spermatids situated near the lumen of the seminiferous tubule
(Figs. 4A and 4C). No specific hybridization was detected withtion. (A) Low-magnification photomicrograph of a mouse seminiferous tubule
s form a band between the basal and the apical regions of the tubule. (B) Low-
930015E06Rik sense riboprobe. Only background silver grains are evident and
tubule. (C) Higher magnification photomicrograph of an area contained in (A).
les corresponding to where secondary spermatocytes and early spermatids are
nd; sc, area of tubule where secondary spermatocytes and early spermatids are
her magnification of an area in (B). No specific hybridization is present over the
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Sertoli cells spans the entire region between the basal lamina
and the lumen of the seminiferous tubule [38]. It is therefore
unlikely that Sertoli cells express significant amounts of
D930015E06Rik mRNA, as we did not detect mRNA for
D930015E06Rik in the apical and basal regions of the semi-
niferous tubule. These findings suggest differential expression
of D930015E06Rik during spermatogenesis, particularly in
secondary spermatocytes and early spermatids, that parallels
that of differentiating erythroblasts. Both processes involve
nuclear condensation, transcriptional silencing of chromatin,
and extensive cellular remodeling in which D930015E06Rik
may play a role. Further studies are under way to localize
D930015E06Rik protein in differentiating erythroblasts and in
spermatocytes.
Two groups of researchers have recently used microarray
profiling [39] and proteomic [40] analyses to identify changes
in gene and protein levels that accompanied the chemically
induced differentiation of murine erythroleukemia (MEL) cells.
MEL cells are erythroblasts that have been transformed by the
Friend leukemia virus. They are not sensitive to EPO and do not
typically complete the differentiation process by extruding their
nuclei to form reticulocytes, but do differentiate to roughly the
orthochromatophilic erythroblast stage [41]. Microarray profil-
ing [39] identified approximately 180 genes that exhibited
significant changes in expression (up or down) during MEL cell
differentiation. Only a small subset of these genes exhibited
patterns of expression that increased during the entire time
course of MEL differentiation and none of our LEBs were
identified in that study. The proteomic study [40] compared
uninduced MEL cells to MEL cells after 2 days of induction
with N,N′-hexamethylene bisacetamide (HMBA). A total of 31
proteins were found to be differentially expressed, of which 27
were identified by mass spectrometry. Fifteen of these were up-
regulated by HMBA and 16 were down-regulated. Again, none
of the LEBs in this article were among the proteins identified to
be up-regulated in differentiating MEL cells.
We have identified three genes not previously described in
differentiating erythroblasts. The relative expression of each of
these genes peaks during the period in which differentiating
erythroblasts are undergoing a dramatic series of morphological
and biochemical changes, suggesting a role for each in one or
more of those processes. Two of the genes have no known
function, while one plays a role in exporting molecules from
the nucleus. The determination of the function of these genes
will likely be facilitated using the FVA cell model in
combination with RNAi and knockout mouse studies since
all are expressed at relatively high levels during the differentia-
tion of erythroblasts.
Materials and methods
Cell culture
FVA cells were prepared as previously described [42]. Briefly, female
CD2F1 mice were injected with 104 spleen focus-forming units of the anemia-
inducing strain of Friend virus. After 2 weeks spleens were harvested from the
mice and immature erythroblasts isolated by unit gravity sedimentation over a1–2% gradient of bovine serum albumin (Intergen Corp., Purchase, NY, USA).
Cells were cultured in 5.0% CO2 in air. The cell culture medium was Iscove's
modified Dulbecco's medium (Invitrogen, Carlsbad, CA, USA) containing 30%
fetal calf serum (Invitrogen), 0.1% deionized bovine serum albumin, 0.1 mM
monothioglycerol, 100 U/ml penicillin, and 1 mg/ml streptomycin. Two units of
EPO per milliliter (Ortho Pharmaceutical Corp., Raritan, NJ, USA) was added
when required.
RNA isolation
Total RNA was extracted from FVA cells and from mouse tissues by a
single-step guanidium thiocyanate–phenol–chloroform extraction method [43].
FVA cells were cultured in the absence of EPO for 30 min at a density of
2×106 cells/ml. At the end of the 30-min preincubation period, 30×106 cells
were used to extract total RNA for the 0 h of culture time point (0 h RNA). FVA
cells for later time points were cultured at an initial density of 1×106/ml. EPO
was added after the 30-min preincubation and the incubation was continued for
34, 38, or 42 h. Total RNAwas isolated from FVA cells at each time point and
combined (late RNA) for use in DDRT PCR. We chose to collect RNA at these
time points to detect gene expression that might increase prior to the time when
FVA cells begin to enucleate in culture [20]. Total RNA was collected and
pooled from multiple early and late samples to minimize mouse-to-mouse
variation in the analysis. Total RNA was also isolated from FVA cells at the
initiation of culture (0 h) and after 2, 24, and 48 h in the presence of EPO to
document levels of gene expression on Northern blots and by RT-PCR.
Differential display reverse transcriptase PCR
DDRT-PCR was based on that of Bauer et al. [44] using 1 anchor primer in
combination with 12 different arbitrary primers. Primers were purchased from
Invitrogen.
Isolation and reamplification of differentially displayed cDNA
Differentially displayed cDNA bands were cut from the dried gels and eluted
using a modification of a previously described procedure [45]. The eluted DNA
was precipitated and dissolved in 10 μl of nuclease-free water. Two microliters
of the eluted DNAwere reamplified to generate cDNA for analysis. The anchor
and arbitrary primers used for the reamplification were the same primers used in
the original DDRT PCR. After the addition of all of the components, the reaction
mixture was overlaid with 50 μl of light mineral oil and subjected to 20 cycles of
amplification using the temperature conditions described for the initial PCR
above. After 20 cycles, the concentration of each of the primers in the reaction
mixture was increased to 10 μM and that of dNTPs to 100 μM. The reaction
mixture was then subjected to another 20 cycles of amplification. Agarose gel
analysis was performed using 15 μl of the reamplified DNA sample to confirm
specificity of the PCR.
Confirmation of differential expression
Slot-blot analysis was used as a secondary screen to confirm the differential
expression of reamplified cDNA bands as previously described [45].
Cloning of differentially expressed cDNA fragments
Differentially expressed cDNA fragments were reamplified once again as
described above. The fresh PCR product was ligated into a TA cloning PCR II or
2.1 vector (Invitrogen) and sequenced.
Northern blots
Northern blots were performed as previously described [42]. Briefly, 15 μg
of total RNA for each sample was resolved on a 1% alkaline agarose gel. Gel
electrophoresis was carried out in the running buffer (1× Mops buffer) for 16–
20 h at 22 V. After gel electrophoresis, gels were soaked in 10× SSC buffer
(pH 7.0, 1.5 M sodium chloride, 1.5 M sodium citrate) twice for 20 min each and
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The membranes were air dried at room temperature, crosslinked in a UV
crosslinker (FB-UVXL-1000; Fisher Scientific, Wayne, NJ, USA), and stored at
40°C until needed. Prehybridization, hybridization, and washing of the blots
were carried out in a hybridization oven (Integrated Separation Systems;
Enprotech, Natick, MA, USA). At the time of the hybridization experiment,
blots were placed into hybridization bottles along with 10 ml of prehybridization
buffer [3 ml of 20× SSC buffer, 5 ml of formamide GR (Fisher Scientific, Fair
Lawn, NJ, USA), 1 ml of 50× Denhardt's solution, 0.5 ml of 10% SDS, 0.5 ml of
nuclease-free water] and prehybridization was allowed to proceed at 42°C for
2–3 h. Random primer-labeled LEB cDNA probes were synthesized using a
Multiprime Random Primer Labeling System (Amersham International plc,
Buckinghamshire, UK) and [α-32P]dCTP (3000 Ci/mmol) (Perkin–Elmer,
Boston, MA, USA). The probes were denatured and added to the prehybridiza-
tion buffer at a concentration of 1×106 cpm/ml. The membranes were then
hybridized at 42°C for 20 h. Blots were washed at 42°C with two changes of
2× SSC/0.5% SDS for 15 min per change. The blots were then washed at 52°C
with three changes of 0.1× SSC/0.1% SDS for 20 min per change. The blots
were air-dried, sealed in plastic bags, and exposed to X-ray film (Fuji Photo Film
Co. Ltd., Japan) with an intensifying screen at −80°C for up to 14 days.
Quantitation of the autoradiographic signals on blots were performed on a
Power Macintosh G4 computer using the public domain ImageJ program. The
expression of each differentially expressed mRNA was normalized to the
amount of 18S RNA in each lane after reprobing the blots with a murine 18S
RNA probe obtained from the American Type Culture Collection (ATCC No.
63178). This method of normalization was chosen since no housekeeping genes
maintained constant levels of expression during the time course of FVA cell
terminal differentiation.
5′-RACE
Additional 5′ sequence information was obtained for LEBs 1–3 using a
commercially available 5′-RACE kit (5′ RACE System for Rapid Amplification
of cDNA ends, version 2.0; Invitrogen). Each RACE reaction required two
gene-specific primers. The first primer was used in the RT reaction to generate
cDNA and the second was used as one of the primers in the PCR amplification
of the RACE product, along with the anchor primer supplied with the kits. The
procedure was performed as described by the manufacturer. 5′-RACE products
were cloned into PCR 2.1 and sequenced. The sequences were then used in
BLASTsearches against the mouse genome to identify candidate genes for each.
PCR amplification
To determine if potential candidate genes identified by BLASTanalysis were
truly being expressed during the terminal differentiation of FVA cells, we
designed primers to amplify segments of the candidate gene cDNAs that were
outside the region contained in the 5′-RACE clones. Primers were designed
using the program GeneJockeyII (Biosoft, Ferguson, MO, USA). The primer
pairs used were as follows (5′–3′): Apoll1, forward, AGCCATTGATAACTT-
CACGG, reverse, ACACAGAGGATGCTGAGAGTGC; Xpo7, forward,
CTGGAAGATACAGGTCTGGTCC, reverse, GCTTCACTAACTTCCTTACG;
D930015E06Rik, forward, CGCTGCCGTGAACCTTCTGC; reverse, ATGTT-
CATCTCCAAGTGTAGCG. Reverse transcription reactions were performed
using 300 ng reverse primer with M-MuLV reverse transcriptase (Promega
Biotech) according to the manufacturer's instructions. PCR was performed
using PCR Master Mix (Promega Biotech) according to the manufacturer's
instructions. PCR products were cloned into the pGEM-T or the pGEM-T Easy
vector (Promega Biotech), sequenced, and compared to the published sequences
of candidate genes in the mouse genome database.
PCR was also used to determine if Apoll1 and D930015E06Rik could be
detected in bone marrow of normal mice. Total RNAwas isolated as described
above from bone marrow extruded from the femur of three different adult female
Balb-c mice. Total RNA was also isolated from half of one kidney from each
mouse to serve as a nonerythroid control tissue. Total RNA was also isolated
from FVA cells after 48 h of culture in the presence of EPO as a positive control
and from testes of one male mouse. Ten micrograms of total RNA from each
sample was treated with Amplification Grade DNase I (Invitrogen) and then
1 μg of the DNase-treated total RNAwas reverse transcribed using SuperScriptIII First Strand Supermix for qRT-PCR (Invitrogen). One microgram DNase-
treated total RNA from each sample was also subjected to a mock RT reaction, in
which all components of the reaction were added, but nuclease-free water was
substituted for the RT-Enzyme Mix to serve as a negative control for PCR. The
RT reactions containing total cDNA or mock reverse-transcribed total RNAwere
diluted from 1:100 to 1:400 and 5 μl of the diluted cDNA was used in three
different 30-μl total volume PCRs (PCR Mastermix; Promega Biotech) to
amplify Apoll1, D930015E06Rik, and GAPDH. The dilution of cDNA that was
used for each sample was the highest that yielded specific and reproducible
amplification of Apoll1 and/or D930015E0Rik. The primer pairs used were
as follows (5′–3′): Apoll1, forward, AAGTCATTGATAACGCCACG, reverse,
GAGGAAACTCTCGCAGAAACCG; D930015E0Rik, forward GGCAGAGA-
CCACTAATACCAGC, reverse, TTGAGTGTTCTCTTCAGGTTGC; GAPDH
forward, CATGTTCCAGTATGACTCCACTC, reverse, GGCCTCACCCCA-
TTTGATGT. The amplimer sizes for each were as follows: Apoll1, 222 bp;
D930015E06Rik, 174 bp; and GAPDH, 136 bp. Products of the PCR were
analyzed on 2.0% agarose gels.
Riboprobe production
Sense and anti-sense D930015E06Rik RNA riboprobes were prepared
following the manufacturer's instructions (Riboprobe in vitro Transcription
Systems; Promega Biotech). Riboprobes were labeled with [α-35S]UTP
(Perkin–Elmer; 1250 Ci/mmol). Phenol/chloroform extracted, SalI-(Promega
Biotech) restricted plasmid was used with T7 RNA polymerase to produce
the sense riboprobe. Sense riboprobes had the same sequence as the
D930015E06Rik mRNA present in the mouse testis and served as a method
of control for nonspecific hybridization of the probe to the tissue. Phenol/
chloroform extracted, SacII-(Promega Biotech) restricted plasmid was used with
SP6 RNA polymerase to produce the antisense riboprobe. The antisense
riboprobe had a sequence complementary to the D930015E06Rik mRNA. The
difference in hybridization between sense (nonspecific) and antisense
(nonspecific plus specific) probes was taken to be specific D930015E06Rik
hybridization.
In situ hybridization
Sections of 4-μm thickness were cut and processed for in situ hybridization
as previously described [46,47]. Briefly, 600,000 cpm of either sense or
antisense D930015E06Rik riboprobe in 30 μl hybridization buffer was applied
to each slide and the sections were sealed under siliconized 24×40-mm
coverslips using rubber cement. Hybridization was allowed to proceed overnight
at 50°C. Coverslips were then removed and the slides were washed for 10 min in
two changes of 4× SSC+10 mM 2-mercaptoethanol (BME) at room
temperature. All slides were then washed in 50% formamide:2× SSC+BME
at 50°C for 30 min, followed by two brief changes of 2× SSC without added
BME. The slides were then subjected to RNase digestion (40 μg/ml RNase A
and 40 U/ml RNase T1 in 2× SSC) at 37°C for 30 min. The slides were again
washed in 50% formamide: 2× SSC+BME at 50°C for 30 min. The slides were
washed at 50°C as follows, and 10 mM BMEwas included in all solutions: three
times for 15 min in 1× SSC, three times for 15 min in 0.5× SSC, and three times
for 15 min in 0.25× SSC. The slides were washed in three changes of 0.1× SSC
without added BME at room temperature; dehydrated through 70, 90, and 100%
ethanol; and subjected to autoradiography and hematoxylin and eosin staining as
previously described. Photomicrographs were taken using an Olympus BH2
microscope equipped with a SPOT RT color camera (Diagnostic Instruments,
Sterling Heights, MI, USA).
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